[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA", "age": 64, "title": "Chief Executive Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 499000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 295000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.59, "open": 3.52, "dayLow": 3.52, "dayHigh": 3.92, "regularMarketPreviousClose": 3.59, "regularMarketOpen": 3.52, "regularMarketDayLow": 3.52, "regularMarketDayHigh": 3.92, "payoutRatio": 0.0, "beta": 0.882, "forwardPE": -17.0, "volume": 51257, "regularMarketVolume": 51257, "averageVolume": 695722, "averageVolume10days": 35810, "averageDailyVolume10Day": 35810, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 15942423, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 29.2, "priceToSalesTrailing12Months": 0.92414486, "fiftyDayAverage": 4.2514, "twoHundredDayAverage": 5.6702, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9549910016, "profitMargins": -0.45341998, "floatShares": 2450907651, "sharesOutstanding": 4262680, "sharesShort": 166481, "sharesShortPriorMonth": 189053, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.044699997, "heldPercentInsiders": 0.04078, "heldPercentInstitutions": 0.0155299995, "shortRatio": 4.72, "shortPercentOfFloat": 0.0448, "impliedSharesOutstanding": 3710940, "bookValue": 0.008, "priceToBook": 467.49997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7822000, "trailingEps": -6.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 553.586, "enterpriseToEbitda": -881.801, "52WeekChange": -0.8701389, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 3.74, "targetHighPrice": 40.0, "targetLowPrice": 12.0, "targetMeanPrice": 26.0, "targetMedianPrice": 26.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 28159000, "totalCashPerShare": 0.011, "ebitda": -10830000, "totalDebt": 12603000, "quickRatio": 1.837, "currentRatio": 2.058, "totalRevenue": 17251000, "debtToEquity": 62.789, "revenuePerShare": 6.0, "returnOnAssets": -0.15356, "returnOnEquity": -0.4594, "grossProfits": 10234000, "freeCashflow": -11746375, "operatingCashflow": -21203000, "revenueGrowth": -0.944, "grossMargins": 0.59324, "ebitdaMargins": -0.62779, "operatingMargins": -7.5756598, "financialCurrency": "USD", "symbol": "BLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "postMarketChangePercent": 0.0, "postMarketPrice": 3.74, "postMarketChange": 0.0, "regularMarketChange": 0.15, "regularMarketDayRange": "3.52 - 3.92", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 695722, "fiftyTwoWeekLowChange": 1.44, "fiftyTwoWeekLowChangePercent": 0.626087, "fiftyTwoWeekRange": "2.3 - 29.2", "fiftyTwoWeekHighChange": -25.460001, "fiftyTwoWeekHighChangePercent": -0.87191784, "fiftyTwoWeekChangePercent": -87.013885, "dividendDate": 1563148800, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "earningsCallTimestampStart": 1755174600, "earningsCallTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.0, "epsForward": -0.22, "epsCurrentYear": -0.795, "priceEpsCurrentYear": -4.7044024, "regularMarketChangePercent": 4.17828, "regularMarketPrice": 3.74, "corporateActions": [], "postMarketTime": 1755893404, "regularMarketTime": 1755892801, "exchange": "NCM", "messageBoardId": "finmb_5015080", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "BioLineRx Ltd.", "longName": "BioLineRx Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1311773400000, "fiftyDayAverageChange": -0.5114, "fiftyDayAverageChangePercent": -0.12028978, "twoHundredDayAverageChange": -1.9301999, "twoHundredDayAverageChangePercent": -0.34041125, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]